BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22928942)

  • 1. Thrombospondin-1-derived 4N1K peptide expression is negatively associated with malignant aggressiveness and prognosis in urothelial carcinoma of the upper urinary tract.
    Miyata Y; Watanabe S; Kanetake H; Sakai H
    BMC Cancer; 2012 Aug; 12():372. PubMed ID: 22928942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pathological Significance and Prognostic Roles of Thrombospondin-1, and -2, and 4N1K-peptide in Bladder Cancer.
    Nakamura Y; Miyata Y; Takehara K; Asai A; Mitsunari K; Araki K; Matsuo T; Ohba K; Sakai H
    Anticancer Res; 2019 May; 39(5):2317-2324. PubMed ID: 31092423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of thrombospondin-derived 4N1K peptide-containing proteins in renal cell carcinoma tissues is associated with a decrease in tumor growth and angiogenesis.
    Miyata Y; Koga S; Takehara K; Kanetake H; Kanda S
    Clin Cancer Res; 2003 May; 9(5):1734-40. PubMed ID: 12738728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.
    Miyata Y; Sagara Y; Watanabe S; Asai A; Matsuo T; Ohba K; Hayashi T; Sakai H
    Virchows Arch; 2013 Nov; 463(5):673-9. PubMed ID: 23975255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
    Ioachim E; Michael MC; Salmas M; Damala K; Tsanou E; Michael MM; Malamou-Mitsi V; Stavropoulos NE
    BMC Cancer; 2006 May; 6():140. PubMed ID: 16732887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.
    Ohtsuka Y; Kawakami S; Fujii Y; Koga F; Saito K; Ando N; Takizawa T; Kageyama Y; Kihara K
    BJU Int; 2006 Jun; 97(6):1322-6. PubMed ID: 16686732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer.
    Harada J; Miyata Y; Araki K; Matsuda T; Nagashima Y; Mukae Y; Mitsunari K; Matsuo T; Ohba K; Mochizuki Y; Sakai H
    In Vivo; 2021; 35(3):1693-1701. PubMed ID: 33910854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of TG-interacting factor is associated with worse prognosis in upper urinary tract urothelial carcinoma.
    Yeh BW; Wu WJ; Li WM; Li CC; Huang CN; Kang WY; Liu ZM; Huang HS
    Am J Pathol; 2012 Sep; 181(3):1044-55. PubMed ID: 22771156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uridine 5'diphospho-glucuronosyltransferase 1A expression as an independent prognosticator in urothelial carcinoma of the upper urinary tract.
    Izumi K; Inoue S; Ide H; Fujita K; Mizushima T; Jiang G; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H
    Int J Urol; 2018 May; 25(5):429-435. PubMed ID: 29444544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
    Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
    Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer.
    Kamai T; Shirataki H; Nakanishi K; Furuya N; Kambara T; Abe H; Oyama T; Yoshida K
    BMC Cancer; 2010 Apr; 10():164. PubMed ID: 20426825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas.
    Donmez G; Sullu Y; Baris S; Yildiz L; Aydin O; Karagoz F; Kandemir B
    Pathol Res Pract; 2009; 205(12):854-7. PubMed ID: 19762163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
    BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract.
    Wu CF; Ng KF; Chen CS; Chang PL; Chuang CK; Weng WH; Liao SK; Pang ST
    Br J Cancer; 2010 Sep; 103(6):852-60. PubMed ID: 20736946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion.
    Kosaka T; Kikuchi E; Mikami S; Miyajima A; Shirotake S; Ishida M; Okada Y; Oya M
    Clin Cancer Res; 2010 Dec; 16(23):5814-23. PubMed ID: 20947514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report.
    Yoshida S; Kobayashi S; Koga F; Ishioka J; Ishii C; Tanaka H; Nakanishi Y; Matsuoka Y; Numao N; Saito K; Masuda H; Fujii Y; Kihara K
    Eur Radiol; 2013 Aug; 23(8):2206-14. PubMed ID: 23494496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
    Miyata Y; Kanda S; Nomata K; Hayashida Y; Kanetake H
    Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer.
    Ishida M; Mikami S; Kikuchi E; Kosaka T; Miyajima A; Nakagawa K; Mukai M; Okada Y; Oya M
    Carcinogenesis; 2010 Feb; 31(2):287-95. PubMed ID: 19755661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma.
    Bagrodia A; Krabbe LM; Gayed BA; Kapur P; Bernstein I; Xie XJ; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclerq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
    Urology; 2014 Nov; 84(5):1134-40. PubMed ID: 25443916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma.
    Miyazaki Y; Kosaka T; Mikami S; Kikuchi E; Tanaka N; Maeda T; Ishida M; Miyajima A; Nakagawa K; Okada Y; Sato Y; Oya M
    Clin Cancer Res; 2012 Aug; 18(15):4145-53. PubMed ID: 22675166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.